GlassScriptPhysician profile
Helene Lacoste
NPI 1629063029
$2,371.77
in general payments reported to CMS, 2019-2025
29 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $207 · 2021: $260 · 2022: $537 · 2023: $400 · 2024: $329 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $947.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $686.80 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $232.29 | 2023-2024 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $189.54 | 2021-2022 | |
| Hologic Sales and Service, LLC | $151.83 | 2021-2025 | Aptima, Myosure Tissue Removal Device, Novasure |
| Exeltis, USA INC. | $132.27 | 2019-2025 | Slynd |
| Organon LLC | $113.06 | 2022-2025 | Nexplanon |
| Astellas Pharma US INC | $85.87 | 2019-2024 | Veozah |
| Pfizer INC. | $82.81 | 2022-2024 | |
| Mylan Pharmaceuticals INC. | $69.52 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.79 | 2019-2022 | |
| Aspira Women'S Health INC | $57.08 | 2023 | Ova1 |
| Coopersurgical, INC. | $57.06 | 2019-2024 | Paragard T 380a |
| Sage Therapeutics, LLC | $44.39 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $40.03 | 2022 | |
| Channel Medsystems, INC. | $39.19 | 2023-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $36.58 | 2022 | |
| Exact Sciences Corporation | $33.62 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Therapeuticsmd, INC. | $32.48 | 2019-2022 | |
| Amgen INC. | $32.08 | 2019 | |
| Amag Pharmaceuticals, INC. | $28.89 | 2019-2020 | |
| Daiichi Sankyo INC. | $25.75 | 2023 | Injectafer |
| Avion Pharmaceuticals | $23.26 | 2020 | |
| Lupin INC. | $19.47 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.08 | 2022 | |
| Baxter Healthcare | $18.69 | 2024 | Perclot |
| Meditrina | $16.65 | 2025 | |
| Merck Sharp & Dohme LLC | $15.25 | 2021 | |
| Scynexis, INC. | $12.68 | 2022 | |
| Zyla Life Sciences, INC. | $11.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helene Lacoste listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.